Month: May 2013

The Score: Updating The Earnings Results For This Quarter

So far for the 1st quarter, earnings (EPS) are coming in better than expected by about 4% overall. Of the 406 companies that have reported within the S&P 500 (ex financials), over 68% have surprised to the upside. Telecom services has been the leading sector while Utilities and Consumer Staples...

Read More

The Market: A Clown Punching Bag (Video)

Sellers keep on hitting it and buyers snap it right back up. It reminds me of that clown punching bag I had when I was just a lad…

When the programs are in buy mode, every dip is bought. Does it ever end?

(The kid is the seller in this depiction)

Rory, what...

Read More

An Idea: Akorn (AKRX) Could Be In Play After Bausch & Lomb Acquisition

Akorn, Inc. develops, manufactures, and markets ophthalmic and injectable pharmaceutical products. The Company sells various diagnostic and therapeutic pharmaceutical products focused primarily on ophthalmology, anesthesia, antidotes, and rheumatology. Akorn also markets ophthalmic surgical instruments and other supplies, and provides contract manufacturing for third parties.

It Valeant Pharma (VRX) is looking to...

Read More